Generation of the induced pluripotent stem cell line SHUTCMi001-A from a patient with double primary lung and colon cancers.

A new iPSC line from a 70-year-old patient with double primary lung and colon cancers maintains normal karyotype and differentiation capacity.

• Why it matters: Understanding genetic susceptibility in patients with multiple primary malignancies can reveal insights into cancer biology and potential treatments.
• What they did: Researchers generated the SHUTCMi001-A iPSC line from a patient with lung squamous cell carcinoma and sigmoid colon adenocarcinoma, confirming its undifferentiated state and three-germ-layer differentiation ability.
• The result: This iPSC line offers a valuable resource for studying the biological features of synchronous multiple primary malignancies and may facilitate future cancer research.